Journal Logo

July/August 2016 - Volume 39 - Issue 4
pp: 165-214

Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 Months

Collart Dutilleul, Pierre; Ryvlin, Philippe; Kahane, Philippe; More

Clinical Neuropharmacology. 39(4):188-193, July/August 2016.